NCT00561704View on ClinicalTrials.gov

Adiponectin in Obese Women With T2DN and Effects by RAS Blocker

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

April 30, 2007

Study Completion Date

October 31, 2007

Conditions
ObeseType 2 DiabetesDiabetic NephropathyGlucose MetabolismAngiotensin II Type 1 Receptor Blockers
Interventions
DRUG

losartan

losartan, 100mg daily,

All Listed Sponsors
lead

Shanghai Jiao Tong University School of Medicine

OTHER

NCT00561704 - Adiponectin in Obese Women With T2DN and Effects by RAS Blocker | Biotech Hunter | Biotech Hunter